Perturbation of host nuclear membrane component RanBP2 impairs the nuclear import of human immunodeficiency virus -1 preintegration complex (DNA)

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Zhang, Ruonan ^a   Mehla, Rajeev ^a   Chauhan, Ashok ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NUCLEAR PROTEIN; PROTEIN RANBP2; REV PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS DNA; CHAPERONE; NUCLEOPORIN; RAN BINDING PROTEIN 2; RAN-BINDING PROTEIN 2; REV PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; REV PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS-1;

ARTICLE; CONTROLLED STUDY; GENE DOSAGE; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PROTEIN DEPLETION; PROTEIN TARGETING; REVERSE TRANSCRIPTION; RNA INTERFERENCE; VIRUS CELL INTERACTION; VIRUS DNA CELL DNA INTERACTION; VIRUS ENTRY; VIRUS REPLICATION; ACTIVE TRANSPORT; BIOLOGICAL MODEL; CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; VIRUS GENOME;

HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

ACTIVE TRANSPORT, CELL NUCLEUS; BASE SEQUENCE; CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; DNA, VIRAL; GENOME, VIRAL; HIV-1; HUMANS; MODELS, BIOLOGICAL; MOLECULAR CHAPERONES; MOLECULAR SEQUENCE DATA; NUCLEAR PORE COMPLEX PROTEINS; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC;

EID: 78650776859     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015620     Document Type: Article

References (69)

1. Fahrenkrog B, Aebi U (2003) The nuclear pore complex: nucleocytoplasmic transport and beyond. Nat Rev Mol Cell Biol 4: 757-766.
2. Devos D, Dokudovskaya S, Williams R, Alber F, Eswar N (2006) Simple fold composition and modular architecture of the nuclear pore complex. Proc Natl Acad Sci U S A 103: 2172-2177.
3. Maco B, Fahrenkrog B, Huang NP, Aebi U (2006) Nuclear pore complex structure and plasticity revealed by electron and atomic force microscopy. Methods Mol Biol 322: 273-288.
4. D'Angelo MA, Hetzer MW (2008) Structure, dynamics and function of nuclear pore complexes. Trends Cell Biol 18: 456-466.
5. Alber F, Dokudovskaya S, Veenhoff LM, Zhang W, Kipper J, et al. (2007) The molecular architecture of the nuclear pore complex. Nature 450: 695-701.
6. Fried H, Kutay U (2003) Nucleocytoplasmic transport: taking an inventory. Cell Mol Life Sci 60: 1659-1688.
7. Isgro TA, Schulten K (2007) Cse1p-binding dynamics reveal a binding pattern for FG-repeat nucleoporins on transport receptors. Structure 15: 977-991.
8. Isgro TA, Schulten K (2007) Association of nuclear pore FG-repeat domains to NTF2 import and export complexes. J Mol Biol 366: 330-345.
9. Frey S, Richter RP, Görlich D (2006) FG-rich repeats of nuclear pore proteins form a three-dimensional meshwork with hydrogel-like properties. Science 314: 815-817.
10. Wu J, Matunis MJ, Kraemer D, Blobel G, Coutavas E (1995) Nup358, a cytoplasmically exposed nucleoporin with peptide repeats, Ran-GTP binding sites, zinc fingers, a cyclophilin A homologous domain, and a leucine-rich region. J Biol Chem 270: 14209-14213.
11. Yokoyama N, Hayashi N, Seki T, Panté N, Ohba T (1995) A giant nucleopore protein that binds Ran/TC4. Nature 376: 184-188.
12. Tran EJ, Wente SR (2006) Dynamic nuclear pore complex: life on the edge. Cell 125: 1041-1053.
13. Hutten S, Wälde S, Spillner C, Hauber J, Kehlenbach RH (2009) The nuclear pore component Nup358 promotes transportin-dependent nuclear import. J Cell Sci 122: 1100-1110.
14. Bernad R, van der Velde H, Fornerod M, Pickersgill H (2004) Nup358/RanBP2 attaches to the nuclear pore complex via association with Nup88 and Nup214/ CAN and plays a supporting role in CRM1-mediated nuclear protein export. Mol Cell Biol 24: 2373-2384.
15. Cullen BR (2003) Nuclear mRNA export: insights from virology. Trends Biochem Sci 28: 419-424.
16. Strebel K (2003) Virus-host interactions: role of HIV proteins Vif, Tat, and Rev. AIDS 17: Suppl 4: S25-34.
17. Malim MH, Hauber J, Le SY, Maizel JV, Cullen BR (1989) The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338: 254-257.
18. Truant R, Cullen BR (1999) The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin betadependent nuclear localization signals. Mol Cell Biol 19: 1210-1217.
19. Bogerd HP, Echarri A, Ross TM, Cullen BR (1998) Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1. J Virol 72: 8627-8635.
20. Meyer BE, Meinkoth JL, Malim MH (1996) Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus Rev proteins: identification of a family of transferable nuclear export signals. J Virol 72: 2350-2359.
21. Suzuki Y, Craigie R (2007) The road to chromatin-nuclear entry of retroviruses. Nat Rev Microbiol 5: 187-196.
22. Bukrinsky MI, Sharova N, Dempsey MP, Stanwick TL, Bukrinskaya AG, et al. (1992) Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci U S A 89: 6580-6584.
23. Goff SP (2001) Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways. J Gene Med 3: 517-528.
24. Bukrinsky MI, Sharova N, McDonald TL, Pushkarskaya T, Tarpley WG, et al. (1993) Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci U S A 90: 6125-6129.
25. Miller MD, Farnet CM, Bushman FD (1997) Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol 71: 5382-5390.
26. Farnet CM, Haseltine WA (1991) Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J Virol 65: 1910-1915.
27. Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, et al. (1993) A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365: 666-669.
28. Rivière L, Darlix JL, Cimarelli A (2010) Analysis of the viral elements required in the nuclear import of HIV-1 DNA. J Virol 2010 Jan; 84(2): 729-39.
29. De Rijck J, Vandekerckhove L, Christ F, Debyser Z (2007) Lentiviral nuclear import: a complex interplay between virus and host. Bioessays 29: 441-451.
30. Fouchier RA, Malim MH (1999) Nuclear import of human immunodeficiency virus type-1 preintegration complexes. Adv Virus Res 52: 275-299.
31. Depienne C, Roques P, Créminon C, Fritsch L, Casseron R, et al. (2000) Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses. Exp Cell Res 260: 387-95.
32. Fouchier RA, Meyer BE, Simon JH, Fischer U, Malim MH (1997) HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J 16: 4531-9.
33. Freed EO, Englund G, Martin MA (1995) Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J Virol 69: 3949-5434.
34. Kootstra NA, Schuitemaker H (1999) Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages. Virology 253: 170-80.
35. Mannioui A, Nelson E, Schiffer C, Felix N, Le Rouzic E, et al. (2005) Human immunodeficiency virus type 1 KK26-27 matrix mutants display impaired infectivity, circularization and integration but not nuclear import. Virology 339: 21-30.
36. Reil H, Bukovsky AA, Gelderblom HR, Göttlinger HG (1998) Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J 17: 2699-708.
37. Agostini I, Popov S, Li J, Dubrovsky L, Hao T, Bukrinsky M (2000) Heat-shock protein 70 can replace viral protein R of HIV-1 during nuclear import of the viral preintegration complex. Exp Cell Res 259: 398-403.
38. Lewis P, Hensel M, Emerman M (1992) Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J 11: 3053-8.
39. Yamashita M, Emerman M (2005) The cell cycle independence of HIV infections is not determined by known karyophilic viral elements. PLoS Pathog 1: e18.
40. König R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, et al. (2008) Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135: 49-60.
41. Woodward CL, Prakobwanakit S, Mosessian S, Chow SA (2009) Integrase interacts with nucleoporin NUP153 to mediate the nuclear import of human immunodeficiency virus type 1. J Virol 83: 6522-6533.
42. Ebina H, Aoki J, Hatta S, Yoshida T, Koyanagi Y (2004) Role of Nup98 in nuclear entry of human immunodeficiency virus type 1 cDNA. Microbes Infect 6: 715-724.
43. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, et al. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science 319: 921-6.
44. Christ F, Thys W, De Rijck J, Gijsbers R, Albanese A, et al. (2008) Transportin-SR2 imports HIV into the nucleus. Curr Biol 18: 1192-1202.
45. Krishnan L, Matreyek KA, Oztop I, Lee K, Tipper CH, et al. (2010) The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. J Virol 84: 397-406.
46. Chauhan A, Turchan J, Pocernich C, Bruce-Keller A, Roth S, et al. (2003) Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J Biol Chem 278: 13512-13519.
47. Chauhan A, Hahn S, Gartner S, Pardo CA, Netesan SK, et al. (2007) Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins. FASEB J 21: 777-789.
48. Vijaykumar, TS, ANath, Chauhan A (2008) Chloroquine mediated molecular tuning of astrocytes for enhanced permissiveness to HIV infection. Virology 381: 1-5.
49. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, et al. (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59: 284-291.
50. Sadaie MR, Benter T, Wong-Staal F (1988) Site-directed mutagenesis of two trans-regulatory genes (tat-III, trs) of HIV-1. Science 239: 910-913.
51. Kutsch O, Benveniste EN, Shaw GM, Levy DN (2002) Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J Virol 76: 8776-8786.
52. Mehla R, Bivalkar-Mehla S, Zhang R, Handy I, Albrecht H, et al. (2010) Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner. PLoS One 5: e11160.
53. Clarke PR (2008) Signaling to nuclear transport. Dev Cell 14: 316-318.
54. Wolff B, Sanglier JJ, Wang Y (1997) Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem Biol 4: 139-147.
55. Luban J (2008) HIV-1 infection: going nuclear with TNPO3/Transportin-SR2 and integrase. Curr Biol 18: R710-713.
56. Suzuki Y, Misawa N, Sato C, Ebina H, Masuda T, et al. (2003) Quantitative analysis of human immunodeficiency virus type 1 DNA dynamics by real-time PCR: integration efficiency in stimulated and unstimulated peripheral blood mononuclear cells. Virus Genes 27: 177-188.
57. Pierson TC, Kieffer TL, Ruff CT, Buck C, Gange SJ, Siliciano RF (2002) Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication. J Virol 76: 4138-44.
58. Butler SL, Johnson EP, Bushman FD (2002) Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles. J Virol 76: 3739-47.
59. Bouyac-Bertoia M, Dvorin JD, Fouchier RA, Jenkins Y, Meyer BE, et al. (2001) HIV-1 infection requires a functional integrase NLS. Mol Cell 7: 1025-1035.
60. Armon-Omer A, Graessmann A, Loyter A (2004) A synthetic peptide bearing the HIV-1 integrase 161-173 amino acid residues mediates active nuclear import and binding to importin alpha: characterization of a functional nuclear localization signal. J Mol Biol 336: 1117-1128.
61. Kamata M, Nitahara-Kasahara Y, Miyamoto Y, Yoneda Y, Aida Y (2005) Importin-alpha promotes passage through the nuclear pore complex of human immunodeficiency virus type 1 Vpr. J Virol 79: 3557-3564.
62. Haffar OK, Popov S, Dubrovsky L, Agostini I, Tang H, et al. (2000) Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. J Mol Biol 299: 359-368.
63. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, et al. (2000) HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101: 173-185.
64. Stevenson M (2000) HIV nuclear import: What's the flap? Nat Med 6: 626-628.
65. Zaitseva L, Cherepanov P, Leyens L,Wilson SJ, Rasaiyaah J, et al. (2009) HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome. Retrovirology 6: 11.
66. Ao Z, Huang G, Yao H, Xu Z, Labine M, et al. (2007) Interaction of human immunodeficiency virus type 1 integrase with cellular nuclear import receptor importin 7 and its impact on viral replication. J Biol Chem 282: 13456-13467.
67. Gallay P, Hope T, Chin D, Trono D (1997) HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc Natl Acad Sci U S A 94: 9825-9830.
68. Gallay P, Stitt V, Mundy C, Oettinger M, Trono D (1996) Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J Virol 70: 1027-1032.
69. Hu C, Saenz DT, Fadel HJ, Walker W, Peretz M, Poeschla EM (2010) The HIV-1 central polypurine tract functions as a second line of defense against APOBEC3G/F. J Virol Sep 15. [Epub ahead of print].